Results 101 to 110 of about 46,297 (193)

A Case of Recurrent In-Stent Restenosis with Abundant Proteoglycan Component [PDF]

open access: bronze, 2003
Bora Yang   +9 more
openalex   +1 more source

The Transcription Factor TWIST‐Related Protein 1 in Atherosclerosis

open access: yesiNew Medicine, Volume 1, Issue 1, December 2025.
ABSTRACT TWIST‐related protein 1 (TWIST1), a basic helix–loop–helix transcription factor, participates in embryonic development and tissue homeostasis. TWIST1 significantly contributes to the pathogenesis of vascular disorders, including pulmonary arterial hypertension, tumor angiogenesis, obesity, and ocular angiogenesis. Functioning as a shear stress‐
Xiuying Li   +5 more
wiley   +1 more source

Morphological Predictors of Restenosis After Coronary Stenting in Humans [PDF]

open access: bronze, 2002
Andrew Farb   +4 more
openalex   +1 more source

Development of a Clinically Relevant Rabbit Model of Acute Laryngeal Injury

open access: yesLaryngoscope Investigative Otolaryngology, Volume 10, Issue 6, December 2025.
ABSTRACT Objectives Acute laryngeal injury (ALgI) is created as a result of endotracheal tube pressure ulcer formation leading to fibrosis and inflammation. This condition often leads to airway obstruction and voice and swallowing dysfunction. This study demonstrates a reliable animal model of ALgI to reproduce the acute wound process seen clinically ...
Ryan Stepp   +9 more
wiley   +1 more source

Stent-induced hypersensitivity leading to refractory in-stent restenosis: a case report

open access: yesJournal of Medical Case Reports
Background Even in the era of new-generation drug-eluting stents, in-stent restenosis remains a common and challenging problem of percutaneous coronary intervention.
Menghuai Ma, Jiong Tang
doaj   +1 more source

Nanocarrier Design for Dual-Targeted Therapy of In-Stent Restenosis

open access: yesPharmaceutics
The injury-triggered reocclusion (restenosis) of arteries treated with angioplasty to relieve atherosclerotic obstruction remains a challenge due to limitations of existing therapies.
Ivan S. Alferiev   +8 more
doaj   +1 more source

Effect of Intracoronary γ-Radiation Therapy on In-Stent Restenosis [PDF]

open access: bronze, 2000
Gary S. Mintz   +14 more
openalex   +1 more source

PRMT1 in Health and Disease: Emerging Perspectives From Molecular Mechanisms to Therapeutic Strategies

open access: yesMedComm, Volume 6, Issue 12, December 2025.
Protein arginine methyltransferase 1 (PRMT1) is a pivotal enzyme that catalyzes the asymmetric dimethylation of arginine residues, thereby functioning as a critical epigenetic regulator of diverse biological processes such as gene expression, RNA splicing, and DNA repair.
Yanqun Luo   +4 more
wiley   +1 more source

Behavior of restenosis after distal unprotected bifurcation left main coronary artery stenting [PDF]

open access: diamond, 2022
Ezz-eldein El-sawy   +3 more
openalex   +1 more source

Biodegradable Stents—A New Option for Benign Central Airway Stenosis

open access: yesRespirology, Volume 30, Issue 12, Page 1176-1183, December 2025.
Airway stenting using conventional stents for benign central airway stenosis has considerable complication rates as well as technical difficulties while placing and removing. Polydioxanone biodegradable stents serve as a feasible alternative for individuals requiring temporary airway support.
Oğuz Karcıoğlu   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy